[go: up one dir, main page]

BR9506098A - Composto oticamente ativo processo para produzir o mesmo promotor de osteogenese agente para evitar ou tratar doenças ósseas promotor para cura de fratura óssea processos para promover a osteogenese e para evitar ou tratar doenças ósseas em um mamífero e uso de um composto oticamente ativo - Google Patents

Composto oticamente ativo processo para produzir o mesmo promotor de osteogenese agente para evitar ou tratar doenças ósseas promotor para cura de fratura óssea processos para promover a osteogenese e para evitar ou tratar doenças ósseas em um mamífero e uso de um composto oticamente ativo

Info

Publication number
BR9506098A
BR9506098A BR9506098A BR9506098A BR9506098A BR 9506098 A BR9506098 A BR 9506098A BR 9506098 A BR9506098 A BR 9506098A BR 9506098 A BR9506098 A BR 9506098A BR 9506098 A BR9506098 A BR 9506098A
Authority
BR
Brazil
Prior art keywords
prevent
active compound
optically active
osteogenesis
promoter
Prior art date
Application number
BR9506098A
Other languages
English (en)
Inventor
Takashi Sohda
Shigehisa Taketomi
Tsuneo Oda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of BR9506098A publication Critical patent/BR9506098A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655363Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
    • C07F9/655372Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/67Phosphorus compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
BR9506098A 1994-12-28 1995-12-27 Composto oticamente ativo processo para produzir o mesmo promotor de osteogenese agente para evitar ou tratar doenças ósseas promotor para cura de fratura óssea processos para promover a osteogenese e para evitar ou tratar doenças ósseas em um mamífero e uso de um composto oticamente ativo BR9506098A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32727594 1994-12-28

Publications (1)

Publication Number Publication Date
BR9506098A true BR9506098A (pt) 1997-12-23

Family

ID=18197308

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506098A BR9506098A (pt) 1994-12-28 1995-12-27 Composto oticamente ativo processo para produzir o mesmo promotor de osteogenese agente para evitar ou tratar doenças ósseas promotor para cura de fratura óssea processos para promover a osteogenese e para evitar ou tratar doenças ósseas em um mamífero e uso de um composto oticamente ativo

Country Status (20)

Country Link
US (2) US6346521B1 (pt)
EP (1) EP0719782B1 (pt)
KR (1) KR960022542A (pt)
CN (1) CN1058718C (pt)
AR (1) AR002018A1 (pt)
AT (1) ATE202782T1 (pt)
AU (1) AU689004B2 (pt)
BR (1) BR9506098A (pt)
CA (1) CA2166152A1 (pt)
DE (1) DE69521595T2 (pt)
DK (1) DK0719782T3 (pt)
ES (1) ES2158034T3 (pt)
FI (1) FI956273A7 (pt)
GR (1) GR3036757T3 (pt)
HU (1) HUT74562A (pt)
NO (1) NO303641B1 (pt)
NZ (1) NZ280745A (pt)
PT (1) PT719782E (pt)
RU (1) RU2162083C2 (pt)
TW (1) TW403757B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910492A (en) * 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
NZ308658A (en) * 1995-06-05 1999-10-28 Takeda Chemical Industries Ltd Sustained release synergistic pharmaceutical composition comprising a non-peptide osteogenetic promoting substance and a biodegradable polymer
US5952512A (en) * 1995-07-24 1999-09-14 Takeda Chemical Industries, Ltd. Production of optically active benzothiepin salts
CA2264131A1 (en) 1996-08-26 1998-03-05 Takeda Chemical Industries, Ltd. Pharmaceutical composition containing osteogenesis-promoting substance
CA2267930A1 (en) * 1996-10-09 1998-04-16 Nobuyuki Takechi A method for producing a microparticle
WO1999065474A2 (en) * 1998-06-15 1999-12-23 Takeda Chemical Industries, Ltd. Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds
US6355672B1 (en) 1998-08-07 2002-03-12 Takeda Chemical Industries, Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
AR020158A1 (es) * 1998-08-12 2002-04-10 Takeda Chemical Industries Ltd Mejorador del factor de induccion para la diferenciacion celular
AU5998799A (en) * 1998-09-30 2000-04-17 Takeda Chemical Industries Ltd. Bone repair materials/artificial bone compositions
HK1052183A1 (zh) * 2000-03-10 2003-09-05 Pharmacia Corporation 制造tetrahydrobenzothiepines的方法
WO2003007916A1 (en) * 2001-07-17 2003-01-30 Teva Pharmaceutical Industries Ltd. Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate
US20050026871A1 (en) * 2002-07-17 2005-02-03 Moshe Flashner-Barak Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
EP1640010A1 (en) * 2003-07-01 2006-03-29 Astellas Pharma Inc. Agent inducing increase in bone mass
CN101686894B (zh) * 2007-06-29 2012-07-25 凯希特许有限公司 骨和软骨形成的激活
CN102325754B (zh) 2009-01-19 2014-03-12 第一三共株式会社 含杂原子的环状化合物
BRPI1013988A2 (pt) 2009-04-06 2016-04-05 Daiichi Sankyo Co Ltd composto, composição farmacêutica , e, uso de um composto ou um sal farmacologicamente aceitável do mesmo
CA2791020A1 (en) 2010-04-28 2011-11-03 Daiichi Sankyo Company, Limited [5,6] heterocyclic compound
DK3040329T3 (en) 2013-08-29 2019-01-28 Kyoto Pharma Ind AROMATIC RELATIONSHIP AND APPLICATION THEREOF IN THE TREATMENT OF DISEASES CONNECTED WITH BONE METABOLISM.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138535A3 (en) * 1983-10-13 1987-01-28 British Telecommunications Plc Visual display logic simulation system
US5158943A (en) * 1988-11-21 1992-10-27 Takeda Chemical Industries, Ltd. Sulfur-containing heterocyclic compounds
DK656789A (da) 1988-12-28 1990-06-29 Takeda Chemical Industries Ltd Benzoheterocykliske forbindelser
DE69132651T2 (de) * 1990-05-30 2001-10-25 Takeda Chemical Industries, Ltd. Schwefel enthaltende heterocyclische Verbindungen
JP3165866B2 (ja) * 1990-06-06 2001-05-14 武田薬品工業株式会社 含硫黄複素環化合物

Also Published As

Publication number Publication date
PT719782E (pt) 2001-10-31
GR3036757T3 (en) 2001-12-31
CA2166152A1 (en) 1996-06-29
RU2162083C2 (ru) 2001-01-20
ATE202782T1 (de) 2001-07-15
AU4069395A (en) 1996-07-04
NO303641B1 (no) 1998-08-10
EP0719782A1 (en) 1996-07-03
NO955305L (no) 1996-07-01
CN1131669A (zh) 1996-09-25
NO955305D0 (no) 1995-12-27
HUT74562A (en) 1997-01-28
FI956273A0 (fi) 1995-12-27
US6632807B1 (en) 2003-10-14
EP0719782B1 (en) 2001-07-04
DK0719782T3 (da) 2001-09-24
DE69521595T2 (de) 2002-05-23
DE69521595D1 (de) 2001-08-09
KR960022542A (ko) 1996-07-18
TW403757B (en) 2000-09-01
AR002018A1 (es) 1998-01-07
HU9503802D0 (en) 1996-02-28
AU689004B2 (en) 1998-03-19
FI956273L (fi) 1996-06-29
NZ280745A (en) 1997-09-22
US6346521B1 (en) 2002-02-12
FI956273A7 (fi) 1996-06-29
ES2158034T3 (es) 2001-09-01
CN1058718C (zh) 2000-11-22

Similar Documents

Publication Publication Date Title
BR9506098A (pt) Composto oticamente ativo processo para produzir o mesmo promotor de osteogenese agente para evitar ou tratar doenças ósseas promotor para cura de fratura óssea processos para promover a osteogenese e para evitar ou tratar doenças ósseas em um mamífero e uso de um composto oticamente ativo
BR8900948A (pt) Composicao aquosa condicionadora de tecidos e processo para tratamento de tecidos
FI954654L (fi) Aminosokeri- ja glykosaminoglykaanikoostumus sidekudosvauroiden hoitoon ja korjaukseen
BR9000990A (pt) Composicao aquosa condicionadora de tecidos e processo para o tratamento de tecidos
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
BR9508586A (pt) Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
BR8900357A (pt) Composicao e processo de tratamento de tecido e processo para a preparacao da dita composicao
BR9600353A (pt) Processo para melhoria da segurança de dispositivos cirúrgicos implantáveis fixados em tecido ósseo e dispositivo cirúrgico
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
FI963696A7 (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
BR8907538A (pt) Processo e composicao de tecido para enxertos
BR9612204A (pt) Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor
BR9503812A (pt) Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto
BR9502471A (pt) Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica
BR9506581A (pt) Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário
BR9707489A (pt) Composto composição farmacêutica e processo para tratar um paciente sofrendo de um distúrbio fisilógico
KR920700634A (ko) 좌창 또는 건선 피부병을 치료하는 방법 및 여기에 사용되는 조성물
BR9708607A (pt) Composto composição farmacéutica utilização de um composto processo para tratamento ou redução do risco de doença inflamatória num paciente e para a preparação de um composto e intermediário químico
BR9708459A (pt) Sistema dispositivo implantável e processo para promover o crescimento em uma direção predeterminada de regenerado de tecido e uso do sistema e do dispositivo
BR9912773A (pt) Processo e aparelho para o tratamento tópico de tecido doente e processo para o tratamento de doenças em vasos do sistema circulatório
BR9106377A (pt) Composicao e processo para o tratamento topico de tecido lesado ou enfermo
BR9710376A (pt) Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano
FI921746A7 (fi) Aineita ja menetelmiä vieraan kudoksen käsittelemiseksi
BR8901135A (pt) Composicao para condicionamento de tecido e processo para tratar tecidos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]